Diagnosis Index entries containing back-references to F15.20: Dependence (on) (syndrome) F19.20 ICD-10-CM Diagnosis Code F19.20 Disorder (of) - see also Disease amphetamine-type substance use moderate F15.20
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
ICD-9-CM codes are very different than ICD-10-CM/PCS code sets:
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
ICD-10 code F15. 21 for Other stimulant dependence, in remission is a medical classification as listed by WHO under the range - Mental, Behavioral and Neurodevelopmental disorders .
Substance use disorders and ICD-10-CM codingMental and Behavioral Disorders due to...Code1...use of opioidsF11...use of cannabisF12...use of sedatives, hypnotics, anxiolyticsF13...use of cocaineF146 more rows•Sep 10, 2015
ICD-10 Code for Other stimulant abuse, uncomplicated- F15. 10- Codify by AAPC.
The ICD-10 code Z86. 4 applies to cases where there is "a personal history of psychoactive substance abuse" (drugs or alcohol or tobacco) but specifically excludes current dependence (F10 - F19 codes with the fourth digit of 2).
ICD-10-CM Diagnosis Code Z79 Z79.
Whereas mild substance use disorder continues to be F1x. 10, moderate substance use disorder continues to be F1x. 20, and severe substance use disorder continues to be F1x. 20, mild substance use disorder in remission is now coded as F1x.